Calidi Biotherapeutics (CLDI) EPS (Weighted Average and Diluted) (2022 - 2025)
Calidi Biotherapeutics' quarterly EPS (Weighted Average and Diluted) came in at $0.45 in Q4 2025, down 93.28% year-on-year from $6.7 in Q4 2024, and up 120.36% quarter-over-quarter from -$2.21 in Q3 2025.
Calidi Biotherapeutics has reported EPS (Weighted Average and Diluted) for 4 years, with the latest figure at $0.45 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 93.28% year-over-year to $0.45; the trailing twelve-month figure through Dec 2025 stood at -$3.93 (up 80.18% YoY), and the FY2025 full-year result was -$5.95, up 83.33% from the prior year.
- EPS (Weighted Average and Diluted) for Q4 2025 stood at $0.45, up from -$2.21 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $6.7 in Q4 2024, with the low at -$16.75 in Q2 2024.
- Average EPS (Weighted Average and Diluted) over 4 years is -$2.07, with a median of -$0.69 recorded in 2022.
- Year-over-year, EPS (Weighted Average and Diluted) sank 9593.33% in 2023 and jumped 171.26% in 2024.
- Tracing CLDI's EPS (Weighted Average and Diluted) over 4 years: stood at $5.07 in 2022, then plunged by 51.28% to $2.47 in 2023, then jumped by 171.26% to $6.7 in 2024, then plunged by 93.28% to $0.45 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.45 (Q4 2025), -$2.21 (Q3 2025), and -$1.99 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 4.02 |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 6.75 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.51 |
| 10 | Calidi Biotherapeutics | - | - | - | 0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.45 |
| Sep 30, 2025 | -2.21 |
| Jun 30, 2025 | -1.99 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | 6.70 |
| Sep 30, 2024 | -7.75 |
| Jun 30, 2024 | -16.75 |
| Mar 31, 2024 | -2.03 |
| Dec 31, 2023 | 2.47 |
| Sep 30, 2023 | -1.41 |
| Jun 30, 2023 | -14.24 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | 5.07 |
| Sep 30, 2022 | -0.63 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.05 |